Stay updated on PRS-343 HER2+ Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the PRS-343 HER2+ Solid Tumors Clinical Trial page.

Latest updates to the PRS-343 HER2+ Solid Tumors Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page's revision tag was updated from v3.6.4 to v3.6.5, indicating a minor update or patch to the page's metadata.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe page shows a new revision tag (v3.6.4) replacing the prior version (v3.6.3), indicating a minor update to the site’s backend or documentation.SummaryDifference0.1%

- Check52 days agoChange DetectedThe page's revision label was updated from v3.6.2 to v3.6.3. This indicates a minor backend/content-management update without changes to the study details.SummaryDifference0.1%

- Check59 days agoChange DetectedThe page's revision tag was updated from v3.6.0 to v3.6.2. This reflects a backend/template update for the ClinicalTrials.gov study page.SummaryDifference0.1%

- Check66 days agoChange DetectedDeleted a large set of keywords and labels that describe the study's target, mechanism, and design (HER2, CD137/4-1BB, PRS-343, dose escalation, expansion cohorts, interventional model, arms and interventions). Related disease context and location references were also removed, reducing the specificity of the trial description.SummaryDifference17%

- Check73 days agoChange DetectedRecruitment status is changed to not enrolling, indicating participants are no longer being sought. New help sections and navigation links (How to Read a Study Record, Common Questions, How to Join a Study) were added, and the Intervention/Treatment heading formatting was updated along with a revision from v3.5.5 to v3.6.0.SummaryDifference0.4%

Stay in the know with updates to PRS-343 HER2+ Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PRS-343 HER2+ Solid Tumors Clinical Trial page.